Inspire IVF Partners with Intrarat Hospital to Elevate Comprehensive Fertility Treatment

Inspire IVF Public Company Limited, Thailand's leading fertility center and assisted reproductive technology provider, continues to raise the standard of care for individuals facing infertility through the signing of a Memorandum of Understanding (MOU) with Intrarat Hospital. The partnership aims to develop a comprehensive treatment network that connects patient care efficiently from diagnosis and infertility treatment to care during pregnancy, as well as maternal and newborn health care after delivery.

This collaboration stems from the shared vision of Mr. Chanachai Chulwirakorn, Chairman of the Executive Board, and Ms. Kasinee Kuldiloke, Chief Executive Officer of Inspire IVF Public Company Limited, together with Mr. Chartnana Navaratorn and Dr. Prapas Teerakul, Director of Intrarat Hospital. Their shared goal is to elevate the standard of infertility treatment in Thailand by combining the strengths of both organizations to deliver more comprehensive, high-quality medical services.

Under this partnership, Inspire IVF will contribute its expertise in reproductive medicine, assisted reproductive technology, and internationally accredited embryology laboratories, integrating these capabilities with the strengths of Intrarat Hospital — which offers an experienced medical team, modern medical equipment, and a multidisciplinary patient care system — to enhance treatment quality across every dimension of care.

In addition, both organizations aim to develop a "Seamless Patient Journey" model of care, ensuring that individuals facing infertility receive continuous support at every stage — from health assessment and personalized treatment planning, through the use of assisted reproductive technologies, to maternal and infant health care — all under high standards of safety and quality.

This MOU signing reflects Inspire IVF Public Company Limited's ongoing commitment to advancing medical innovation, raising the standard of infertility treatment, and expanding its network of medical partnerships to increase the chances of successful family-building for patients. It also reinforces Thailand's position as a regional hub for infertility treatment and assisted reproductive technology.